BSET vs MED
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BSET shows bearish fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Concerns include weak profitability or high valuation.
Medifast exhibits severe operational distress, highlighted by a weak Piotroski F-Score of 2/9 and a catastrophic YoY EPS decline of 1750%. While the company maintains a fortress balance sheet with very low debt (Debt/Equity 0.05) and high liquidity (Current Ratio 4.69), these strengths are overshadowed by a collapsing top line (-36.9% revenue growth). The stock is trading at a deep discount to book value (P/B 0.57), but the fundamental trajectory suggests a 'value trap' rather than a recovery opportunity.
Compare Another Pair
Related Comparisons
BSET vs MED: Head-to-Head Comparison
This page compares Bassett Furniture Industries, Incorporated (BSET) and Medifast, Inc. (MED) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.